A61B2017/00889

DISSIMILAR STAPLE CARTRIDGES WITH DIFFERENT BIOABSORBABLE COMPONENTS
20220370065 · 2022-11-24 ·

Stapling devices and staple cartridges are disclosed. A stapling device can include a jaw configured to sequentially receive a plurality of dissimilar staple cartridges having different bioabsorbable components. An adjustment module can implement a firing control algorithm based on which dissimilar staple cartridge is received in the jaw. A staple cartridge can include staples comprised of a bioabsorbable metal alloy and configured to degrade at a staple degradation rate over an expected staple life in the patient. A staple cartridge can also include an implantable layer comprised of a bioabsorbable polymer and configured to degrade at a layer degradation rate over an expected layer life in the patient. The staple degradation rate and the implantable degradation rate can be different. The implantable layer can mechanically support at least a portion of a staple for a time in the expected staple life.

METHOD FOR DELIVERING A STAPLE IN SITU PAIRED TO THE IN SITU ENVIRONMENT
20220370064 · 2022-11-24 ·

A method of pairing bioabsorbable staples in a staple cartridge with the tissue being treated such that the staples are structurally sufficient during the healing window of the tissue but completely bioabsorb shortly thereafter.

VASCULAR CLOSURE DEVICES AND METHODS PROVIDING HEMOSTATIC ENHANCEMENT
20220370055 · 2022-11-24 ·

Vascular closure devices and methods for closing a blood vessel puncture site disposed at a distal end of a tissue tract are described. A combination of the body's own natural mechanism with chemical and/or biological agents is relied upon to accelerate the hemostatic process. Included are steps of introducing a closure device through the tissue tract and deploying an expansible member at a distal end of the device within the blood vessel to occlude the puncture site. A sealing member disposed proximal the expansible member is then displaced by retracting and tensioning a coil spring so as to expose a chemical and/or biological region or release region of the device. The retraction and tensioning of the coil spring is limited by a coupling member. Exposure of blood and tissue to the chemical and/or biological sealing member promotes the clotting processing to accelerate the occlusion process in the tract.

Layer of material for a surgical end effector

In various embodiments, a layer of material can comprise a body, a proximal end portion, and a distal end portion. The proximal end portion can be releasably secured to a staple cartridge of a surgical end effector, and the distal end portion can be releasably secured to an anvil of the surgical end effector. The layer of material can comprise a tissue thickness compensator.

Non-pneumatic surgical tourniquet
11504134 · 2022-11-22 · ·

A non-pneumatic tourniquet including a tourniquet ring configured to resiliently constrict around a body part of a subject. The tourniquet ring defines a plurality of openings. A handle moves the tourniquet ring onto the body part and includes a first strap having a first end secured to the tourniquet ring at one of the openings and a second end secured to the tourniquet ring at one of the openings. A second strap has a first end secured to the tourniquet ring at one of the openings and a second end secured to the tourniquet ring at one of the openings.

Three dimensional adjuncts

Stapling assemblies for use with a surgical stapler and methods for manufacturing the same are provided. Three dimensional adjuncts for use with a surgical stapling assembly and methods for manufacturing the same are also provided.

Bleeding control device
11583285 · 2023-02-21 ·

A bleeding control device for mitigating bleeding includes an outer storage container housing, a compressed gas canister, wound blocking contents and a control element. The bleeding control device may be used to deliver variable contents to a wound at the site of injury to control the bleeding of a victim as temporary solution for mitigating the bleeding until more advanced medical care can be provided. A bleeding control device includes a canister housing, a compressed gas canister arranged within the canister housing, a tube connected to the canister housing, an inflatable balloon disposed on the tube, the inflatable balloon being fluidly connected to the compressed gas canister, and a control element configured to activate the compressed gas canister to inflate the inflatable balloon.

Negative Pressure Wound Therapy Device Having Helical Elements

A device is configured for use in negative pressure wound therapy (NPWT). The device includes a tube having a tube proximal end and a tube distal end and A coil having a plurality of windings extending from a coil proximal end to a coil distal end. The coil distal end is coupled to the tube proximal end in a manner that enables application of a negative pressure from within the coil through the coil to tissue surrounding the coil. The coil comprises a space between adjacent ones of the plurality of windings, the space having a predetermined dimension.

BIOABSORBABLE STAPLE COMPRISING MECHANISMS FOR SLOWING THE ABSORPTION OF THE STAPLE

A surgical staple comprising a substrate and one or more coatings which slows the bioabsorption of the substrate. The coating can be selected so as to affect the environment surrounding the staple once the staple is implanted in the patient. The effect on the environment can cause the bioabsorption to occur within a desired time frame.

SKIN MORPHING AND TENSION DISTRIBUTING SYSTEM FOR EXTERNAL FIXATION AND METHODS OF USE THEREOF

Kits and systems are disclosed that include one or more segments of elastically deformable membrane in combination with one or more external fixation members and optionally in combination with one or more tension protector pads. Also disclosed are methods of use of the kits and systems in methods that involve stretching the elastically deformable membrane and applying the stretched membrane to the skin of a patient, and releasing the tension on the membrane, thus causing compression of the skin to which the membrane is applied. The method may further include the optional steps of inserting one or more external fixation members through the membrane/skin combination and into a bone segment, applying a distraction force to the one or more external fixation members, and adjusting one or more segments of membrane to affect skin tension at a rate that is similar to a rate at which the distraction force is applied.